Showing results (231-240 of 317) with videos related to

Sort By:
Pageof 32
La Ricerca in Clinica E in Laboratorio|January 1, 1986
Adoptive immunotherapy of cancer with immune and activated lymphocytes: experimental and clinical studiesG Parmiani, M L Sensi, A Balsari, et al.
Cancer Research|September 29, 1998
Targeting of interleukin 2 to human ovarian carcinoma by fusion with a single-chain Fv of antifolate receptor antibodyC Melani, M Figini, D Nicosia, et al.
The Journal of Clinical Investigation|September 1, 1992
Cell retargeting by bispecific monoclonal antibodies. Evidence of bypass of intratumor susceptibility to cell lysis in human melanomaP Nisticò, R Mortarini, L B De Monte, et al.
International Journal of Cancer|May 15, 1988
In vivo activation of lymphocytes in melanoma patients receiving escalating doses of recombinant interleukin 2C Gambacorti-Passerini, M Radrizzani, R Marolda, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 14, 1998
Pilot study of subcutaneous recombinant human interleukin 12 in metastatic melanomaE Bajetta, M Del Vecchio, R Mortarini, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1986
Systemic administration of autologous, alloactivated helper-enriched lymphocytes to patients with metastatic melanoma of the lung. A phase I studyA Balsari, R Marolda, C Gambacorti-Passerini, et al.
Tumori|June 30, 1989
A phase II study of the administration of recombinant interleukin 2 (rIL-2) plus lymphokine activated killer (LAK) cells in stage IV melanoma patientsN Cascinelli, F Belli, S Marchini, et al.
Cancer Research|February 2, 1999
A superagonist variant of peptide MART1/Melan A27-35 elicits anti-melanoma CD8+ T cells with enhanced functional characteristics: implication for more effective immunotherapyL Rivoltini, P Squarcina, D J Loftus, et al.
Histology and Histopathology|August 21, 2007
Epigenetic remodelling of DNA in cancerA A Lettini, M Guidoboni, E Fonsatti, et al.
International Journal of Cancer|November 28, 2000
T cell responses in colorectal cancer patients: evidence for class II HLA-restricted recognition of shared tumor-associated antigensA J Bremers, S Andreola, E Leo, et al.
Pageof 32